PARTNERSHIPS


An important factor in apceth Biopharma’s research and development strategy is cooperation with renowned clinical, academic and research organizations. Some of the world’s leading experts in the field of cell and gene therapy, oncology, immune oncology, immunomodulation and other relevant disease areas participate in our efforts to develop efficient, safe and better tolerable MSC-based gene therapeutics.

This approach strengthens apceth Biopharma’s R&D work. In addition, partnerships with international biotech companies complement pharmaceutical development of our therapeutics by providing not only state-of-the-art expertise but also platform technologies.

apceth-pipes-cooperation
LMU-Munich-cooperation
LMU-Munich-Klinikum
Helmholtz-Zentrum-Munich-cooperation
MHH-Hanover-cooperation
Charité-Berlin-cooperation
CMMC-Cologne-cooperation
IBMT-Fraunhofer Institute
UKE-Hamburg
IBET
ISAR-Klinikum-cooperation

MEMBERSHIPS IN INDUSTRIAL ASSOCIATIONS


LMU-Munich-cooperation

BIO Deutschland

Verband Forschender Arzneimittelhersteller e.v. (vfa)

Verband Forschender Arzneimittelhersteller e.v. (vfa)

Dr. Guenther, apceth Biopharma’s CEO, is a member of the vfa bio’s executive board.

Gesellschaft für Chemische Technik und Biotechnologie e.V. (DECHEMA)

Gesellschaft für Chemische Technik und Biotechnologie e.V. (DECHEMA)